Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11402488 | 0.87 | PDPK1 (0.43) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 | |
| SCHEMBL5712479 | 0.87 | HSP90AA1 (0.45) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 | |
| Bromide SCHEMBL2363115 | 0.86 | HSP90AA1 (0.44) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 | |
| Isobutyramide SCHEMBL28478427 | 0.84 | ADORA2A (0.40) | PDPK1LOXL2MAOAHSP90AA1ALDH1A1 | |
| SCHEMBL1954807 | 0.82 | PDPK1 (0.46) | PDPK1RAB9ALOXL2CYP2A6MAOA | |
| SCHEMBL29658188 | 0.82 | PDPK1 (0.53) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 | |
| SCHEMBL23297 | 0.82 | PDPK1 (0.53) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 | |
| SCHEMBL5945842 | 0.80 | PDPK1 (0.52) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 | |
| SCHEMBL14862855 | 0.80 | HSP90AA1 (0.45) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 | |
| SCHEMBL10576992 | 0.80 | CASP6 (0.44) | PDPK1RAB9ALOXL2CYP2A6HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096975-A1 | ACTIVE INGREDIENT COMBINATIONS OF ALKYLAMIDOTHIAZOLES AND ONE OR MORE BIOPOLYMERS | BEIERSDORF AG (DE) | 2026-04-09 | — | — | US | disclosed |
| CN-120000585-A | Novel drug-assisted precursor micelle preparation and production method thereof | 酰莱(合肥)生命科学研发有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119775221-A | Preparation method of isobutyramide thiazolyl resorcinol | 河南旭瑞新材料科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119488443-A | Combinations of one or more alkylamidothiazoles and one or more alkyl sarcosinates and cosmetic formulations containing such combinations | 妮维雅(上海)有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-118845489-A | Liquid crystal emulsion compound and preparation method and application thereof | 广州珍颜堂医药生物科技有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118615189-A | Low-irritation whitening agent dispersion system and preparation method thereof | 丝纳特（苏州）生物科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| US-7125428-B2 | 1,3-Dihydroxybenzene derivatives and colorants containing said compounds | WELLA AG (DE) | 2006-10-24 | — | — | US | disclosed |
| US-20040016063-A1 | 1,3-Dihydroxybenzene derivatives and colorants containing said compounds | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2004-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040016063-A1 | 1,3-Dihydroxybenzene derivatives and colorants containing said compounds | KRT18, DSP, COL1A1 | PDPK1 2067/4885RAB9A 3237/4885LOXL2 1869/4885 |
| US-20260096975-A1 | ACTIVE INGREDIENT COMBINATIONS OF ALKYLAMIDOTHIAZOLES AND ONE OR MORE BIOPOLYMERS | TYR, GALE, GALK1 | PDPK1 690/4885RAB9A 347/4885LOXL2 1554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.